Jubaan is developing the Gixam™ System, a non-invasive, AI imaging platform designed to predict the presence of GI disorders by analyzing the spectral signature on the tongue generated by the oral microbiome. As a first step, Jubaan is focusing on the early detection of colorectal adenomas aiming to replace fecal occult blood test (FOBT) and fecal immunochemistry test (FIT) as a first step colorectal cancer screening tool.